Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Transrail Lighting Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Q1 FY27 revenue grew 5% year-on-year, reaching INR 1,736 crores, with management confident of better execution in H2 and subsequent quarters. Key concall…
26 Aug 2026
Entero Healthcare Solutions Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Profit after tax (PAT) saw substantial growth in Q1, with a PAT margin of 2.7%; the company is focused on sustaining and building on this margin. Key concall…
26 Aug 2026
Supriya Lifescience Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
1,000 crores by FY '27, reflecting strong demand and robust product pipeline. Key concall takeaways from Supriya Lifescience Ltd's Q1 FY27 earnings call — and…
26 Aug 2026
Powerica Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
As of July 31, 2026, Powerica's order book showed a 15% to 19% year-on-year growth. Key concall takeaways from Powerica Ltd's Q1 FY27 earnings call — and how…
26 Aug 2026
Aditya Birla Fashion & Retail Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
10% space addition). Key concall takeaways from Aditya Birla Fashion & Retail's Q1 FY27 earnings call — and how it ranks against sector peers.
26 Aug 2026
AXISCADES Tech. Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
The company sees a huge defense order pipeline exceeding ₹24,000 crore, with execution visibility till FY30. Key concall takeaways from AXISCADES Tech.'s Q1…
26 Aug 2026
Nephrocare Health Services Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
International operations contribute around 45% of revenue, reflecting their growing importance in overall growth. Key concall takeaways from Nephrocare Health…
26 Aug 2026
Rain Industries Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
. Key concall takeaways from Rain Industries Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
26 Aug 2026
India Glycols Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Chemicals business shows 25% YoY revenue growth; pipeline strong in performance chemicals. Key concall takeaways from India Glycols Ltd's Q1 FY27 earnings call…
26 Aug 2026
Annapurna Swadisht Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
1,100 crore top line by FY '28, with a PAT exceeding Rs. Key concall takeaways from Annapurna Swadisht Ltd's Q1 FY27 earnings call — and how it ranks against…
26 Aug 2026
Religare Enterprises Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Broking business is in a repair and investment phase with intentions to build a new growth model; Q1 FY27 revenue increased 7% YoY with a 53% increase in PBT…
26 Aug 2026
V2 Retail Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Volume growth of 56% was achieved in the latest quarter, aligned with store expansion. Key concall takeaways from V2 Retail Ltd's Q1 FY27 earnings call — and…
26 Aug 2026
Max Estates Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
16,000 crores GDV planned for FY '27 and beyond, with about Rs. Key concall takeaways from Max Estates Ltd's Q1 FY27 earnings call — and how it ranks against…
26 Aug 2026
K.P. Energy Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
2,250 crores (2.16 GW), providing substantial revenue visibility. Key concall takeaways from K.P. Energy Ltd's Q1 FY27 earnings call — and how it ranks against…
26 Aug 2026
Regaal Resources Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Ongoing capex of approximately INR 540 crores planned for completion in FY 2026-27; INR 401 crores already spent by March 31, 2026, with remaining ~INR 140…
26 Aug 2026
Regaal Resources Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Value-added product share rising sharply from 3% in FY’26 to 20-22% in FY’27, driving better margins. Key concall takeaways from Regaal Resources Ltd's Q1 FY27…
26 Aug 2026
Brainbees Solutions Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Non-diapering consumables (~15% of GMV) continue growing robustly, contributing healthily to margins. Key concall takeaways from Brainbees Solutions Ltd's Q1…
26 Aug 2026
Rategain Travel Technologies Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
They are experiencing almost 200% growth in this order book segment. Key concall takeaways from Rategain Travel Technologies Ltd's Q4 FY26 earnings call — and…
26 Aug 2026
Tega Industries Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
. Key concall takeaways from Tega Industries Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
26 Aug 2026
Olectra Greentec Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Current orders around INR300 crores; capacity enhancement underway. Key concall takeaways from Olectra Greentec's Q1 FY27 earnings call — and how it ranks…
26 Aug 2026